Source:http://linkedlifedata.com/resource/pubmed/id/12086760
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9323
|
pubmed:dateCreated |
2002-6-27
|
pubmed:abstractText |
The worldwide increase in type 2 diabetes mellitus is becoming a major health concern. We aimed to assess the effect of acarbose in preventing or delaying conversion of impaired glucose tolerance to type 2 diabetes.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0140-6736
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
359
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2072-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12086760-Acarbose,
pubmed-meshheading:12086760-Blood Glucose,
pubmed-meshheading:12086760-Diabetes Mellitus, Type 2,
pubmed-meshheading:12086760-Female,
pubmed-meshheading:12086760-Glucose Intolerance,
pubmed-meshheading:12086760-Humans,
pubmed-meshheading:12086760-Hypoglycemic Agents,
pubmed-meshheading:12086760-Male,
pubmed-meshheading:12086760-Middle Aged
|
pubmed:year |
2002
|
pubmed:articleTitle |
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial.
|
pubmed:affiliation |
Research Centre, Centre Hospitalier de l'Université de Montréal, Hôtel-Dieu, Department of Medicine, University of Montreal, Quebec, Canada. jean.louis-chiasson@umontreal.ca
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|